Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Y Walley

Showing results (71-80 of 261) with videos related to

Pageof 27
Sort By:
Addiction (Abingdon, England)|January 10, 2020
Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphineTae Woo Park, Marc R Larochelle, Richard Saitz, et al.
Journal of Substance Abuse Treatment|June 7, 2021
"It could potentially be dangerous... but nothing else has seemed to help me.": Patient and clinician perspectives on benzodiazepine use in opioid agonist treatmentTae Woo Park, Jennifer Sikov, Vanessa dellaBitta, et al.
Drug and Alcohol Dependence|May 15, 2019
Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohortJake R Morgan, Bruce R Schackman, Zoe M Weinstein, et al.
JAMA Network Open|August 29, 2024
Pharmacy Naloxone Standing Order and Community Opioid Fatality Rates Over TimeZiming Xuan, Alexander Y Walley, Shapei Yan, et al.
Research in Social & Administrative Pharmacy : RSAP|January 28, 2020
Pharmacy leaders' beliefs about how pharmacies can support a sustainable approach to providing naloxone to the communityElizabeth Donovan, Jeffrey Bratberg, Janette Baird, et al.
AIDS Patient Care and Stds|January 17, 2014
Patient perspectives of an integrated program of medical care and substance use treatmentMari-Lynn Drainoni, Caitlin Farrell, Amy Sorensen-Alawad, et al.
Harm Reduction Journal|July 29, 2022
Effect of police action on low-barrier substance use disorder service utilizationKarrin Weisenthal, Simeon D Kimmel, Jessica Kehoe, et al.
JAMA Network Open|April 4, 2025
Trends in Extended-Release and Non-Extended-Release Buprenorphine DispensingThomas J Stopka, Netrali Dalvi, Leonard D Young, et al.
Addiction Science & Clinical Practice|February 7, 2014
2013 Update in addiction medicine for the generalistAdam J Gordon, Nicolas Bertholet, Jennifer McNeely, et al.
Journal of Health Politics, Policy and Law|January 19, 2022
How Do Medicaid Agencies Improve Substance Use Treatment Benefits? Lessons from Three States' 1115 Waiver ExperiencesErika Crable, David K Jones, Alexander Y Walley, et al.
Pageof 27

Showing results (71-80 of 261) with videos related to

Sort By:
Pageof 27
Addiction (Abingdon, England)|January 10, 2020
Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphineTae Woo Park, Marc R Larochelle, Richard Saitz, et al.
Journal of Substance Abuse Treatment|June 7, 2021
"It could potentially be dangerous... but nothing else has seemed to help me.": Patient and clinician perspectives on benzodiazepine use in opioid agonist treatmentTae Woo Park, Jennifer Sikov, Vanessa dellaBitta, et al.
Drug and Alcohol Dependence|May 15, 2019
Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohortJake R Morgan, Bruce R Schackman, Zoe M Weinstein, et al.
JAMA Network Open|August 29, 2024
Pharmacy Naloxone Standing Order and Community Opioid Fatality Rates Over TimeZiming Xuan, Alexander Y Walley, Shapei Yan, et al.
Research in Social & Administrative Pharmacy : RSAP|January 28, 2020
Pharmacy leaders' beliefs about how pharmacies can support a sustainable approach to providing naloxone to the communityElizabeth Donovan, Jeffrey Bratberg, Janette Baird, et al.
AIDS Patient Care and Stds|January 17, 2014
Patient perspectives of an integrated program of medical care and substance use treatmentMari-Lynn Drainoni, Caitlin Farrell, Amy Sorensen-Alawad, et al.
Harm Reduction Journal|July 29, 2022
Effect of police action on low-barrier substance use disorder service utilizationKarrin Weisenthal, Simeon D Kimmel, Jessica Kehoe, et al.
JAMA Network Open|April 4, 2025
Trends in Extended-Release and Non-Extended-Release Buprenorphine DispensingThomas J Stopka, Netrali Dalvi, Leonard D Young, et al.
Addiction Science & Clinical Practice|February 7, 2014
2013 Update in addiction medicine for the generalistAdam J Gordon, Nicolas Bertholet, Jennifer McNeely, et al.
Journal of Health Politics, Policy and Law|January 19, 2022
How Do Medicaid Agencies Improve Substance Use Treatment Benefits? Lessons from Three States' 1115 Waiver ExperiencesErika Crable, David K Jones, Alexander Y Walley, et al.
Pageof 27